21 results
8-K
EX-2.1
IKNA
Ikena Oncology Inc
7 Aug 23
Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction
8:02am
of whether they are classified as exempt or non-exempt for purposes of the Fair Labor Standards Act, as amended and any similar state law. The Company … employee, applicant for employment, or consultant of the Company.
(o) The Company currently classifies and has properly classified each of its employees
10-K
ziofd
17 Mar 22
Annual report
6:31am
10-Q
chatrttd ft2l
13 May 21
Quarterly report
4:15pm
8-K
EX-3.1
c8a4kin
30 Mar 21
Departure of Directors or Certain Officers
12:00am
424B4
7re6sck m8tn7
26 Mar 21
Prospectus supplement with pricing info
5:04pm
S-1/A
xcs wgpom85zq
22 Mar 21
IPO registration (amended)
8:51am
S-1/A
EX-10.3
wtr9h jymyows2
22 Mar 21
IPO registration (amended)
8:51am
S-1/A
EX-3.3
avcob xqs
22 Mar 21
IPO registration (amended)
8:51am
S-1
m726fuwt hir
5 Mar 21
IPO registration
2:59pm
DRS/A
xrs1kba9h68q0w
11 Feb 21
Draft registration statement (amended)
12:00am